Lacosamide Tablet, Film Coated
Product Images NDC 10135-799

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 10135-799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lac-12 (Lac 12)

Kaplan-Meier curve depicting time to second PGTC seizure in a clinical study (Modified Full Analysis Set). The graph compares the proportion of patients without seizure events over time (in days) between Lacosamide and placebo groups, with survival probabilities on the y-axis and days on the x-axis. Patient numbers at risk are shown below the x-axis.*

FDA Label Image

Lacosamide-01 (Lacosamide 01)

Chemical structure of lacosamide showing its molecular arrangement with functional groups including an amide, methoxy group, and a phenyl ring.*

FDA Label Image

Lacosamide-02 (Lacosamide 02)

A bar graph showing the median percent reduction in seizure frequency over 28 days from baseline to the maintenance phase by dose across three studies for Lacosamide (VIMPAT). The graph compares placebo and various doses of VIMPAT (200, 400, 600 mg/day) with seizure reduction percentages labeled above each bar. Statistically significant differences compared to placebo are marked with an asterisk.*

FDA Label Image

Lacosamide-03 (Lacosamide 03)

A line graph titled 'Figure 2 – Proportion of Patients by Responder Rate for VIMPAT and Placebo Groups in Studies 2, 3, and 4,' showing responder rates from -100% (worsening) to 100% (improvement) on the vertical axis, and percent of patients from 0 to 100 on the horizontal axis. Four lines represent placebo and VIMPAT doses of 200 mg/day, 400 mg/day, and 600 mg/day, illustrating changes in patient response rates across different groups.*

FDA Label Image

Lacosamide-04 (Lacosamide 04)

Packaging label for Lacosamide Tablets, USP 50 mg, film-coated oral tablets. The carton contains 60 unit-dose tablets (6 x 10). Labeler is Marlex Pharmaceuticals, Inc. The label includes a pharmacist instruction to dispense the accompanying Medication Guide and lists the NDC number 10135-799-86.*

FDA Label Image

Lacosamide-05 (Lacosamide 05)

Lacosamide Tablets USP 100 mg film-coated tablets packaging label showing a carton for 60 unit-dose tablets (6 x 10). Label includes dosage strength, unit-dose count, and manufacturer Marlex Pharmaceuticals, Inc. The label specifies prescription use (Rx only) and features barcodes and storage instructions.*

FDA Label Image

Lacosamide-06 (Lacosamide 06)

Lacosamide Tablets, USP 150 mg film-coated oral tablets in a carton label by Marlex Pharmaceuticals, Inc. The package contains 60 unit-dose tablets (6 x 10). The label includes dosage strength, quantity, and manufacturer information with barcode and pharmacy instructions.*

FDA Label Image

Lacosamide-07 (Lacosamide 07)

Packaging label for Lacosamide Tablets, USP 200 mg oral film-coated tablets from Marlex Pharmaceuticals, Inc. The label indicates a package size of 60 unit-dose tablets (6 strips of 10). It includes dosage strength prominently in green, the product name, usage instructions for pharmacists, and barcodes.*

FDA Label Image

Lacosamide-08 (Lacosamide 08)

Lacosamide Tablets USP 50 mg film-coated tablet label showing the product name, strength, and form. The label includes dispensing instructions for pharmacists, storage conditions, manufacturer and distributor details (Marlex Pharmaceuticals, Inc., and Medley Pharmaceuticals Ltd.), package quantity of 60 tablets, and a barcode. The label is for oral human prescription use.*

FDA Label Image

Lacosamide-09 (Lacosamide 09)

Lacosamide Tablets, USP 100 mg film-coated oral tablets label. The package contains 60 tablets and is labeled for prescription use only. Manufactured by Medley Pharmaceuticals Ltd in India and distributed by Marlex Pharmaceuticals, Inc in New Castle, Delaware, USA. The label includes dosage storage instructions, barcode, and batch identification fields.*

FDA Label Image

Lacosamide-10 (Lacosamide 10)

Label for Lacosamide Tablets, USP 150 mg film-coated oral tablets by Marlex Pharmaceuticals, Inc. This carton contains 60 tablets. The label includes storage instructions, manufacturer and distributor information, and a barcode. It states that each tablet contains 150 mg Lacosamide and indicates prescription-only status.*

FDA Label Image

Lacosamide-11 (Lacosamide 11)

Label for Lacosamide Tablets, USP 200 mg film-coated tablets. The label includes dosage information, storage instructions, and manufacturer details. It states the product contains 60 tablets, is distributed by Marlex Pharmaceuticals, Inc, and manufactured by Medley Pharmaceuticals Ltd in India for Kanchan Healthcare Inc. Barcode and NDC number 10135-802-60 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.